Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: A prospective observational study

BMC Family Practice

Volumn 10, Issue , 2009, Pages

  Jeschke, Elke ^a   Ostermann, Thomas ^b   Vollmar, Horst C ^b,c   Kröz, Matthias ^a   Bockelbrink, Angelina ^d   Witt, Claudia M ^d   Willich, Stefan N ^d   Matthes, Harald ^a  

^a Havelhoehe Research Institute   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c FRAUNHOFER INSTITUTE FOR SYSTEMS AND INNOVATION RESEARCH ISI   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG COMBINATION; DRUG UTILIZATION; FEMALE; GERMANY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVATION; PROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; COMPLEMENTARY THERAPIES; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GERMANY; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; OBSERVATION; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 74549137330     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-10-78     Document Type: Article

References (52)

1. Global burden of hypertension: analysis of worldwide data. PM Kearney M Whelton K Reynolds P Muntner PK Whelton J He, Lancet 2005 365 9455 217 223 15652604
2. [Epidemiology of hypertension in Germany and worldwide]. C Prugger PU Heuschmann U Keil, Herz 2006 31 4 287 293 10.1007/s00059-006-2818-6 16810468
3. [Blood pressure in Germany - current status and trends]. M Thamm, Gesundheitswesen 1999 61 90 93
4. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. K Wolf-Maier RS Cooper JR Banegas S Giampaoli HW Hense M Joffres M Kastarinen N Poulter P Primatesta F Rodriguez-Artalejo, et al. JAMA 2003 289 18 2363 2369 10.1001/jama.289.18.2363 12746359
5. Zentralinstitut für die kassenärztliche Versorgung in der Bundesrepublik Deutschland. Ergebnisse: Panel-Basisstatistik. http://www.zi-berlin.de/morbilitaetsanalyse/downloads/ADT-Panel-version3.pdf
6. M Anlauf, Arzneiverordnungs-Report 2006. Aktuelle Daten, Kosten, Trends und Kommentare Springer Verlag, Schwabe U, Paffrath D, 2006
7. [Knowledge of guideline recommendations among internists and general practitioners regarding the diagnosis and treatment of arterial hypertension]. CA Schneider J Hagemeister H Pfaff G Mager HW Hopp, Z Arztl Fortbild Qualitatssich 2001 95 5 339 344 11486497
8. Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German university hospital. S Harder P Thurmann C Thierolf H Klepzig, Int J Clin Pharmacol Ther 1998 36 4 195 201 9587045
9. Economic implications of evidence-based prescribing for hypertension: can better care cost less? MA Fischer J Avorn, JAMA 2004 291 15 1850 1856 10.1001/jama.291.15.1850 15100203
10. [New Hypertension Guidelines - Need for Action among General Practitioners?]. HCRM Vollmar U Popert M Butzlaff, Zeitschrift für Allgemeinmedizin 2004 80 6 237 242 10.1055/s-2004-822624
11. German Hypertension Society. Leitlinien zur Behandlung der arteriellen Hypertonie. http://www.paritaet.org/RR-Liga/
12. Patient safety in guideline-based decision support for hypertension management: ATHENA DSS. MK Goldstein BB Hoffman RW Coleman SW Tu RD Shankar M O'Connor S Martins S Martins A Advani MA Musen, Proc AMIA Symp 2001 214 218 11825183
13. Impact on hypertension control of a patient-held guideline: a randomised controlled trial. B McKinstry J Hanley D Heaney L McCloughan R Elton DJ Webb, Br J Gen Pract 2006 56 532 842 847 17132351
14. Herbal medicines as diuretics: a review of the scientific evidence. CI Wright L Van-Buren CI Kroner MM Koning, J Ethnopharmacol 2007 114 1 1 31 10.1016/j.jep.2007.07.023 17804183
15. Extending practical medicine: fundamental principles based on the science of the spirit. R Steiner I Wegmann, GA 27 Bristol: Rudolf Steiner Press 2000 1 144
16. Hawthorn: potential roles in cardiovascular disease. WT Chang J Dao ZH Shao, Am J Chin Med 2005 33 1 1 10 10.1142/S0192415X05002606 15844828
17. Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA II) cardiac insufficiency: results of an observational cohort study. D Schroder M Weiser P Klein, Eur J Heart Fail 2003 5 3 319 326 10.1016/S1388-9842(02)00237-4 12798830
18. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. MN Ghayur AH Gilani, J Cardiovasc Pharmacol 2005 45 1 74 80 10.1097/00005344-200501000-00013 15613983
19. [The effects of Cardiodoron on cardio-respiratory coordination - a literature review]. D Cysarz C Heckmann HC Kummell, Forsch Komplementarmed Klass Naturheilkd 2002 9 5 292 297 10.1159/000067523 12417806
20. Complementary/alternative medicine for hypertension: a mini-review. E Ernst, Wien Med Wochenschr 2005 155 17-18 386 391 10.1007/s10354-005-0205-1 16392435
21. Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria. OC Amira NU Okubadejo, BMC Complement Altern Med 2007 7 30 10.1186/1472-6882-7-30 17903257
22. Prevalence and pattern of use of complementary and alternative medicine (CAM) in hypertensive patients of a tertiary care center in India. N Shafiq M Gupta S Kumari P Pandhi, Int J Clin Pharmacol Ther 2003 41 7 294 298 12875345
23. Use of complementary therapies in patients with cardiovascular disease. GY Yeh RB Davis RS Phillips, Am J Cardiol 2006 98 5 673 680 10.1016/j.amjcard. 2006.03.051 16923460
24. An approach for integrating complementary-alternative medicine into primary care. MA Frenkel JM Borkan, Fam Pract 2003 20 3 324 332 10.1093/fampra/cmg315 12738703
25. Why don't physicians follow clinical practice guidelines? A framework for improvement. MD Cabana CS Rand NR Powe AW Wu MH Wilson PA Abboud HR Rubin, JAMA 1999 282 15 1458 1465 10.1001/jama.282.15.1458 10535437
26. Primary care physicians' use of lumbar spine imaging tests: effects of guidelines and practice pattern feedback. DK Freeborn D Shye JP Mullooly S Eraker J Romeo, J Gen Intern Med 1997 12 10 619 625 10.1046/j.1525-1497.1997. 07122.x 9346458
27. Implementation barriers for general practice guidelines on low back pain a qualitative study. H Schers M Wensing Z Huijsmans M van Tulder R Grol, Spine (Phila Pa 1976) 2001 26 15 348 353 11474367
28. Factors affecting general practitioners' decisions about plain radiography for back pain: implications for classification of guideline barriers - a qualitative study. A Espeland A Baerheim, BMC Health Serv Res 2003 3 1 8 10.1186/1472-6963-3-8 12659640
29. Ein Pharmakovigilanzsystem für Arzneimittel der besonderen Therapierichtungen. HTM Matthes E Jeschke, EHK 2008 57 34 39 10.1055/s-2008-1044005
30. Remedies Containing Asteraceae Extracts: A Prospective Observational Study of Prescribing Patterns and Adverse Drug Reactions in German Primary Care. E Jeschke T Ostermann C Lüke M Tabali M Kröz A Bockelbrink MC Witt SN Willich H Matthes, Drug Saf 2009 32 8 1 16 10.2165/00002018-200932080-00007 19132801
31. Profiling Anthroposophic Medicine in Daily Practice - A Web-based, Prospective Multicentre Study. E Jeschke T Ostermann M Tabali A Bockelbrink MC Witt SN Willich H Matthes, Forsch Komplementmed
32. [Good practice of secondary data analysis, first revision]. Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten der Deutschen Gesellschaft für Sozialmedizin und Prävention; Arbeitsgruppe Epidemiologische Methoden der Deutschen Gesellschaft für Epidemiologie; Deutschen Gesellschaft für Medizinische Informatik; Biometrie und Epidemiologie; Deutschen Gesellschaft für Sozialmedizin und Prävention, Gesundheitswesen 2008 70 1 54 60 10.1055/s-2007-1022529 18273764
33. [QuaDoSta - ein frei konfigurierbares System zur Unterstützung multizentrischer Datenerhebungen in medizinischer Versorgung und Forschung.]. E Jeschke F Schad J Pissarek B Matthes U Albrecht H Matthes, GMS Med Inform Biom Epidemiol 2007 3 2 oc10
34. Kasenärztliche Bundesvereinigung: Grunddaten zur vertragsärztlichen Versorgung 2008. http://www.zi-berlin.de/ morbilitaetsanalyse/downloads/ADT-Panel-version3.pdf
35. A Simple Method of Sample Size Calculation for Linear and Logistic Regression. FY Hsieh DA Block MD Larsen, Statistics in Medicine 1998 17 1623 1634 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S 9699234
36. The effect of tai chi exercise on blood pressure: a systematic review. GY Yeh C Wang PM Wayne RS Phillips, Prev Cardiol 2008 11 2 82 89 18401235
37. [Considerations about treatment programs of elderly patients with hypertension]. H Li LT Liu, Zhong Xi Yi Jie He Xue Bao 2009 7 7 607 610 10.3736/jcim20090702 19615312
38. High prevalence and poor control of hypertension in primary care: cross-sectional study. AM Sharma HU Wittchen W Kirch D Pittrow E Ritz B Goke H Lehnert D Tschope P Krause M Hofler, et al. J Hypertens 2004 22 3 479 486 10.1097/00004872-200403000-00009 15076152
39. Patterns of antihypertensive drug utilization in primary care. D Pittrow W Kirch P Bramlage H Lehnert M Hofler T Unger AM Sharma HU Wittchen, Eur J Clin Pharmacol 2004 60 2 135 142 10.1007/s00228-004-0731-6 15042351
40. CAM therapies among primary care patients using opioid therapy for chronic pain. S Fleming DP Rabago MP Mundt MF Fleming, BMC Complement Altern Med 2007 7 15 10.1186/1472-6882-7-15 17506893
41. Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer. C Lawsin K DuHamel SH Itzkowitz K Brown H Lim L Thelemaque L Jandorf, Support Care Cancer 2007 15 5 557 564 10.1007/s00520-006- 0198-3 17205277
42. Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis. L Shinto V Yadav C Morris JA Lapidus A Senders D Bourdette, Mult Scler 2006 12 1 94 100 10.1191/1352458506ms1230oa 16459725
43. Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use. FL Bishop GT Lewith, Evid Based Complement Alternat Med 2008 18955327
44. Identifying hypertension-related comorbidities from administrative data: what's the optimal approach? AM Borzecki AT Wong EC Hickey AS Ash DR Berlowitz, Am J Med Qual 2004 19 5 201 206 10.1177/106286060401900504 15532912
45. The attitudes, behaviors and beliefs of patients of conventional vs. complementary (alternative) medicine. A Furnham J Forey, J Clin Psychol 1994 50 3 458 469 10.1002/1097-4679(199405)50:3<458::AID-JCLP2270500318>3.0.CO;2-V 8071452
46. Population trends in antihypertensive drug use: results from the MONICA Augsburg Project 1984 to 1995. C Gasse J Stieber A Doring U Keil HW Hense, J Clin Epidemiol 1999 52 7 695 703 10.1016/S0895-4356(99)00035-9 10391663
47. Gender, age and deprivation differences in the primary care management of hypertension in Scotland: a cross-sectional database study. E Pears PC Hannaford MW Taylor, Fam Pract 2003 20 1 22 31 10.1093/fampra/20.1.22 12509366
48. Factors associated with differences in antihypertensive drug treatment: results from the MONICA Augsburg Population Surveys 1989/90 and 1994/95. C Gasse HW Hense J Stieber A Doring AD Liese G Heller U Keil, Soz Praventivmed 2002 47 2 128 142 10.1007/BF01318395 12134731
49. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Q Gu VL Burt R Paulose-Ram CF Dillon, Am J Hypertens 2008 21 7 789 798 10.1038/ajh.2008.185 18451806
50. Reactive modifications of the autonomous time structure in the human organism. G Hildebrandt, J Physiol Pharmacol 1991 42 1 5 27 1932773
51. [Prescribing practices in the treatment of upper respiratory tract infections in anthroposophic medicine]. E Jeschke C Luke T Ostermann M Tabali J Hubner H Matthes, Forsch Komplementmed 2007 14 4 207 215 10.1159/000104171 17848797
52. Treatment of hypertension in patients 80 years of age or older. NS Beckett R Peters AE Fletcher JA Staessen L Liu D Dumitrascu V Stoyanovsky RL Antikainen Y Nikitin C Anderson, et al. N Engl J Med 2008 358 18 1887 1898 10.1056/NEJMoa0801369 18378519